• Phytol Assay Design: From RXR to Phase Behavior

  2026-08-28

  Phytol assay design requires more than selecting an RXR endpoint: solvent, isomer composition, concentration state, and biological context can reshape interpretation. This article connects Phytol receptor pharmacology with a polymer self-assembly study to develop a practical, evidence-aware workflow for advanced experiments.

• InstaBlue Protein Stain Solution Guide

  2026-08-27

  Learn how InstaBlue Protein Stain Solution (SKU B8226) can strengthen protein-level quality control around cell viability, proliferation, and cytotoxicity studies. This scenario-based guide covers workflow design, compatibility, protocol parameters, quantitative interpretation, and practical vendor selection.

• N-MYC–eIF4G1 Signaling in inv(16) AML

  2026-08-27

  Peramangalam et al. identify an N-MYC–eIF4G1 survival axis that sustains inv(16) acute myeloid leukemia and connect it to a previously unrecognized MYCN enhancer. The study integrates transcriptomic analysis, regulatory-element characterization, functional perturbation, primary leukemia models, and patient-derived xenografts to define a mechanistic basis for targeting this pathway.

• MLN4924 Workflow for NEDD8 Pathway Studies

  2026-08-26

  Use MLN4924 to connect NAE blockade with CRL substrate turnover, cell-cycle disruption, and stress-associated NEDD8 aggregates. This practical workflow also shows how to translate the latest N4BP1 findings into imaging, biochemical, and cancer biology assays.

• Canagliflozin and Proximal Tubule Mitochondria

  2026-08-26

  A 2025 study shows that canagliflozin influences both mitochondrial architecture and bioenergetics in proximal tubular cells from hypertensive–diabetic mice, extending interpretation of SGLT2 inhibition beyond glucose lowering. The male-predominant improvement in respiration, ATP production, membrane potential, and mitochondrial network organization provides a useful framework for renal metabolism studies while highlighting the importance of sex-stratified analysis.

• Isoprenaline Hydrochloride for Heart-Brain Models

  2026-08-25

  Isoprenaline Hydrochloride, also called isoproterenol, provides a controllable way to model β-adrenergic overactivation across cardiac, vascular, pulmonary, and heart-brain experiments. This guide translates its receptor pharmacology into practical workflows, assay choices, and troubleshooting strategies for reproducible preclinical research.

• BOP Reagent: From Peptide Chemistry to Prodrugs

  2026-08-25

  BOP reagent is more than a peptide coupling reagent: it can serve as a disciplined chemistry tool for building reproducible amino acid derivatives, linker intermediates, and prodrug architectures. This analysis connects its activation mechanism and workflow controls with the translational lessons of a carrier-free, ROS-responsive triterpene strategy for oral squamous cell carcinoma.

• NSC 87877: Shp2 Inhibitor Workflows

  2026-08-24

  NSC 87877 enables controlled interrogation of Shp2/Shp1 catalytic activity across EGF signaling, microglial inflammation, and leukemia models. This practical guide connects the compound to the Nespas/miR-383-3p/SHP2 stroke pathway while separating established evidence from proposed assay workflows.

• Anlotinib and Angiogenesis: VEGFR2, PDGFRβ, FGFR1

  2026-08-23

  The reference study shows that anlotinib suppresses VEGF-, PDGF-BB-, and FGF-2-driven angiogenesis by inhibiting VEGFR2, PDGFRβ, FGFR1, and downstream ERK signaling. Its combination of endothelial migration, tube formation, aortic ring, and CAM assays provides a useful preclinical framework for evaluating multi-target tyrosine kinase inhibitors in cancer research.

• Cy5 amine (non-sulfonated): Labeling Guide

  2026-08-22

  Cy5 amine (non-sulfonated), SKU A8143, provides a primary amine for covalent fluorescent labeling with compatible activated esters, activated carboxyl groups, and epoxides. It is appropriate for controlled protein, peptide, polymer, microscopy, and flow-cytometry workflows, but its water insolubility requires preparation in DMSO or ethanol and makes direct addition to aqueous samples unsuitable.

• Selonsertib and the Gal-1–Autophagy Stress Axis

  2026-08-21

  Selonsertib (GS-4997) provides a selective way to test whether ASK1 stress signaling contributes to Galectin-1–linked autophagy failure, steatosis, and insulin resistance. This article translates the latest Gal-1–FIP200 findings into a rigorous, falsifiable assay strategy rather than assuming ASK1 is the upstream cause.

• PKM2 Inhibition: From Glycolysis to Translation

  2026-08-20

  PKM2 inhibitor (compound 3k) illustrates how selective metabolic intervention can connect tumor-cell glycolysis with immunometabolic regulation. This thought-leadership perspective integrates product benchmarks, macrophage biology, translational study design, and the limitations that should guide next-stage validation.

• AI-10-49: Mapping Fusion Disruption in AML

  2026-08-20

  AI-10-49 is a selective CBFβ-SMMHC inhibitor for acute myeloid leukemia research. This article presents a readout-first framework linking target engagement, RUNX1 reactivation, MYCN/eIF4G1 signaling, and leukemia phenotypes.

• Berberine, SIRT6-AMPK, and NLRP3 in AF

  2026-08-19

  This study identifies SIRT6-AMPK signaling as a protective axis in angiotensin II-induced atrial remodeling and links its impairment to NLRP3 inflammasome activation and atrial fibrillation susceptibility. Through human tissue analysis, bioinformatics, and causal mouse experiments, it shows that berberine limits fibrosis, oxidative stress, and inflammatory remodeling in part by restoring this pathway.

• Toremifene Citrate: From Receptor Data to Models

  2026-08-19

  Toremifene Citrate is an oral selective estrogen receptor modulator with applications spanning receptor assays, breast cancer research, and translational pharmacology. This guide presents an assay-to-model framework that connects receptor potency, cellular response, exposure, and study design.

443 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page